Keywords
BiologyCancer researchGeneGene expressionGene expression profilingJUNBCTGFGeneticsGrowth factorReceptor
Affiliated Institutions
Related Publications
Activation of HIF1α ubiquitination by a reconstituted von Hippel-Lindau (VHL) tumor suppressor complex
Mutations in the VHL tumor suppressor gene result in constitutive expression of many hypoxia-inducible genes, at least in part because of increases in the cellular level of hypo...
Induction of the growth inhibitor IGF-binding protein 3 by p53
Transcriptional activation of target genes represents an important component of the tumour-suppressor function of p53 and provides a functional link between p53 and various grow...
Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours
Tumour growth is angiogenesis-dependent; brain tumours have more intense neovascularisation than other tumours and produce basic fibroblast growth factor, a potent angiogenic me...
MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells
miR-7 (microRNA-7) has been characterized as a tumour suppressor in several human cancers. It targets a number of proto-oncogenes that contribute to cell proliferation and survi...
Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor Protein
The von Hippel-Lindau tumor suppressor protein (pVHL) has emerged as a key factor in cellular responses to oxygen availability, being required for the oxygen-dependent proteolys...
Publication Info
- Year
- 2000
- Type
- article
- Volume
- 19
- Issue
- 54
- Pages
- 6297-6305
- Citations
- 264
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
264
OpenAlex
Cite This
Charles C. Wykoff,
Christopher W. Pugh,
Patrick H. Maxwell
et al.
(2000).
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.
Oncogene
, 19
(54)
, 6297-6305.
https://doi.org/10.1038/sj.onc.1204012
Identifiers
- DOI
- 10.1038/sj.onc.1204012